FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Elbit Imaging Ltd. Stock AnalysisComprehensive stock analysis for Elbit Imaging Ltd. (EMITF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEMITF
EMITF
Elbit Imaging Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
EMITF
Home🔹Stocks🔹Elbit Imaging Ltd.

Elbit Imaging Ltd.

EMITF•OTC

Elbit Imaging Ltd.

EMITF•OTC
Market cap
$20.06M
Sentiment

Your view on EMITF

Mkt Cap
$20.06M
Sentiment
Your view
EMITF
Elbit Imaging Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
EMITF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Elbit Imaging Ltd.

Industry
Medical - Devices
Sector
Healthcare
CEO
Eran Mazor
Headquarters
3 Shimson Street, Petah Tikva, IL
Industry
Medical - Devices
Sector
Healthcare
CEO
Eran Mazor
Headquarters
3 Shimson Street, Petah Tikva, IL
Description

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News